date:Aug 01, 2018
l shortly publish a blueprint on how well press forward and implement additional steps to address antimicrobial resistance in veterinary settings. This blueprint will serve as the FDAs new, five-year plan. Well include key goals, objectives and actions that CVM will focus on during fiscal years 2019 2023.
Our new activities will be aimed at addressing three key goals:
Aligning antimicrobial drug product use with the principles of antimicrobial stewardship; supporting efforts to foster better